Plio Ltd - Net Worth and Insider Trading
Plio Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Plio Ltd owns 1 companies in total, including Karyopharm Therapeutics Inc (KPTI) .
Click here to see the complete history of Plio Ltd’s form 4 insider trades.
Insider Ownership Summary of Plio Ltd
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KPTI | Karyopharm Therapeutics Inc | 2013-11-05 | 10 percent owner |
Plio Ltd Trading Performance
Plio Ltd Ownership Network
Ownership Network List of Plio Ltd
Ownership Network Relation of Plio Ltd

Plio Ltd Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Plio Ltd is the 10 percent owner of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include director & President and CEO Richard A. Paulson , EVP & Chief Medical Officer Reshma Rangwala , and EVP & Chief Development Officer Stuart Poulton .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Plio Ltd made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 171,388 shares made by Richard A. Paulson , a net sale of 48,301 shares made by Michael Mason , and a net sale of 40,658 shares made by Stuart Poulton .
In summary, during the past 3 months, insiders sold 26,551 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 26,551 shares. During the past 18 months, 162,839 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 162,839 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Plio Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for Plio Ltd. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Plio Ltd's mailing address is: Larnaca G4 Cy.